News FDA drops PreCert report, new digital health guidances The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digit
Views & Analysis Digital health round-up: the health-tech convergence puzzle How many pieces are left of the puzzle?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
